Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia

NCT02739984 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

424

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Mixed Dyslipidemia
Type 2 Diabetes

Interventions

BIOLOGICAL: Evolocumab
DRUG: Placebo to Evolocumab

Sponsor

Amgen